TDSPharm Co Ltd
KOSDAQ:464280
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
TDSPharm Co Ltd
KOSDAQ:464280
|
KR |
|
R
|
Rockworth PCL
SET:ROCK
|
TH |
|
Reliance Worldwide Corporation Ltd
F:0EU
|
AU |
Intrinsic Value
The intrinsic value of TDSPharm Co Ltd (464280) under the Base Case is 7 770.06 KRW per share. Compared with the current market price of 4 415 KRW, the stock appears Undervalued by 43% .
The intrinsic value is calculated using the DCF method. The model assumes revenue grows about 20% in 2026, then slows: about 6% a year on average over the next five years, . Net margin ends at 15% by 2031, below last year's 15%.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What TDSPharm Does
TDSPharm Co Ltd is a South Korean pharmaceutical company that makes and sells medicines. It earns money mainly by selling finished drug products, either directly or through distributors, to the healthcare market.
- Headquarters
- Korea KR
- Employees
- 111
- IPO date
- Aug 21, 2024
Earnings Waterfall
TDSPharm Co Ltd
The intrinsic value for TDSPharm Co Ltd (464280) under the Base Case is 7 770.06 KRW.
Compared with the current market price of 4 415 KRW, the stock appears Undervalued by 43% .